Source: EURLEX
Language: en
Format: md

Order of the General Court (Sixth Chamber) of 7 April 2022 –  
Dr. August Wolff v EUIPO – Combe International (Vagisan)

(Case T‑679/20)

(EU trade mark – Invalidity proceedings – International registration designating the European Union – Word mark Vagisan – Cross-claim – Subject matter of the action – No interest in bringing proceedings – Inadmissibility)

| 1. | EU trade mark – Appeals procedure – Persons entitled to appeal and to be parties to the proceedings – Persons whose claims are not upheld by a decision – Decision upholding an application for a declaration of invalidity based on part of the arguments – No interest in bringing proceedings – Inadmissibility  (European Parliament and Council Regulation 2017/1001, Art. 72(4))  (see paras 21-23) |

| 2. | EU trade mark – Appeals procedure – Action before the EU judicature – Power of the General Court to alter the contested decision – Limits  (European Parliament and Council Regulation 2017/1001, Art. 72(3))  (see para. 27) |

Operative part

| 1. | The cross-claim is dismissed as being inadmissible. |

| 2. | Combe International LLC shall bear its own costs and pay those incurred by the European Union Intellectual Property Office (EUIPO) in the proceedings relating to the cross-claim. |

| 3. | Dr. August Wolff GmbH & Co. KG Arzneimittel shall bear its own costs of the proceedings relating to the cross-claim. |

[Top](#document1)